HGANMDA:一个异质图对抗网络多模式微生物药物协会预测预测.
Dong Ye1,2, Ziliang Li3, Susu Cui4
1The School of Computer Science and Technology, Soochow University, Suzhou 215006, China.
Journal of chemical information and modeling
|December 17, 2025
概括
预测微生物药物协会 (MDAs) 对抗微生物药物治疗至关重要. 一个新的异质图对抗网络 (HGANMDA) 通过捕获复杂的生物网络模式来提高预测准确性.
科学领域:
- 生物医学信息学是生物医学信息学.
- 计算生物学是一种计算生物学.
- 网络药理学 网络药理学
背景情况:
- 准确的微生物药物协会 (MDA) 预测对于抗微生物治疗和药物重新定位至关重要.
- 实验验证是昂贵和耗时的.
- 现有的模型在异质和多尺度的生物医学网络相互作用方面扎.
研究的目的:
- 开发一种先进的计算模型,用于预测微生物与药物之间的关联.
- 为了解决捕获复杂生物网络结构的当前方法的局限性.
主要方法:
- 开发了HGANMDA,一个异质图形对抗网络.
- 将综合多式生物数据整合到一个统一的异质图表中.
- 采用了基于注意力的聚合的多通道结构编码器.
- 引入了对抗式嵌入规范化,以提高稳定性和特征可分离性.
主要成果:
- 在三个基准数据集上,HGANMDA在多个指标上始终超过了最先进的基线模型.
- 在预测微生物与药物关联方面表现优异.
- 验证了拟议的异质图形学习方法的有效性.
结论:
- 逆向规范化的异质图学习显示了促进抗菌研究的巨大潜力.
- HGANMDA提供了一种强大而准确的方法来预测微生物与药物之间的关联.
- 这些发现支持在药物发现和开发中使用先进的网络学习技术.
更多相关视频
相关概念视频
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Combined Effects of Drugs: Antagonism
11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Agonism and Antagonism: Quantification
942
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
942
Estimation of k and VD of Aminoglycosides
193
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
193
Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K


